2.09
price down icon1.66%   -0.02
 
loading
Schlusskurs vom Vortag:
$2.11
Offen:
$2.12
24-Stunden-Volumen:
209.60K
Relative Volume:
0.25
Marktkapitalisierung:
$148.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.50M
KGV:
-0.8708
EPS:
-2.4
Netto-Cashflow:
$-114.31M
1W Leistung:
+10.96%
1M Leistung:
+9.21%
6M Leistung:
+14.64%
1J Leistung:
-13.18%
1-Tages-Spanne:
Value
$2.06
$2.14
1-Wochen-Bereich:
Value
$1.84
$2.215
52-Wochen-Spanne:
Value
$1.31
$2.74

Nkarta Inc Stock (NKTX) Company Profile

Name
Firmenname
Nkarta Inc
Name
Telefon
(925) 407-1049
Name
Adresse
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Name
Mitarbeiter
157
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
NKTX's Discussions on Twitter

Vergleichen Sie NKTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NKTX
Nkarta Inc
2.085 149.87M 0 -117.50M -114.31M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.17 119.17B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
810.41 84.19B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
407.74 52.77B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
811.40 48.98B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
175.73 36.31B 447.02M -1.18B -906.14M -6.1812

Nkarta Inc Stock (NKTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-15 Herabstufung William Blair Outperform → Mkt Perform
2024-10-09 Eingeleitet Rodman & Renshaw Buy
2024-08-14 Hochstufung Raymond James Outperform → Strong Buy
2024-03-22 Herabstufung Raymond James Strong Buy → Outperform
2022-12-22 Herabstufung Oppenheimer Outperform → Perform
2022-10-10 Eingeleitet Canaccord Genuity Buy
2022-07-28 Eingeleitet Needham Buy
2022-07-18 Eingeleitet SVB Leerink Outperform
2022-03-11 Eingeleitet Raymond James Outperform
2022-03-08 Eingeleitet H.C. Wainwright Buy
2022-01-06 Eingeleitet William Blair Outperform
2021-11-18 Eingeleitet SMBC Nikko Outperform
2021-07-16 Eingeleitet Oppenheimer Outperform
2020-08-04 Eingeleitet Cowen Outperform
2020-08-04 Eingeleitet Evercore ISI Outperform
2020-08-04 Eingeleitet Mizuho Buy
2020-08-04 Eingeleitet Stifel Buy
Alle ansehen

Nkarta Inc Aktie (NKTX) Neueste Nachrichten

pulisher
Jan 08, 2026

Can Nkarta Inc. stock double in next 5 yearsTrade Volume Summary & Accurate Buy Signal Notifications - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Nkarta Inc. stock attractive for passive investors2025 Major Catalysts & Precise Buy Zone Identification - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Nkarta Inc. stock affected by interest rate hikesWeekly Stock Recap & Expert Approved Trade Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Dec 31, 2025

The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals

Dec 31, 2025
pulisher
Dec 27, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Dec 27, 2025
pulisher
Dec 27, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 27, 2025
pulisher
Dec 25, 2025

Analysts’ Recent Ratings Updates for Nkarta (NKTX) - Defense World

Dec 25, 2025
pulisher
Dec 20, 2025

Nkarta Shares Show Signs of Finding a Floor - AD HOC NEWS

Dec 20, 2025
pulisher
Dec 20, 2025

How strong is Nkarta Inc. stock balance sheetJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why Nkarta Inc. stock is favored by top institutions2025 Volume Leaders & Daily Technical Stock Forecast Reports - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Portfolio Recap: Is Nkarta Inc. stock attractive for growth ETFsJuly 2025 Action & Fast Gain Stock Tips - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Nkarta (NASDAQ:NKTX) Rating Increased to Hold at Wall Street Zen - Defense World

Dec 20, 2025
pulisher
Dec 19, 2025

Is Nkarta Inc. stock a safe buy before earningsJuly 2025 Price Swings & Weekly Stock Breakout Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Nkarta, Inc.(NasdaqGS: NKTX) dropped from NASDAQ Biotechnology Index - marketscreener.com

Dec 18, 2025
pulisher
Dec 16, 2025

What analysts say about Nkarta Inc stockPortfolio Diversification Tips & High Profit Trading Alerts - earlytimes.in

Dec 16, 2025
pulisher
Dec 13, 2025

Nkarta, Inc. $NKTX Shares Sold by AWM Investment Company Inc. - Defense World

Dec 13, 2025
pulisher
Dec 11, 2025

This trade activity should not be overlooked: Nkarta Inc (NKTX) - setenews.com

Dec 11, 2025
pulisher
Dec 07, 2025

VIX Spike: Why analysts upgrade STVN stockWeekly Market Report & Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ

Dec 07, 2025
pulisher
Dec 07, 2025

Nkarta (NASDAQ:NKTX) Downgraded by Wall Street Zen to Sell - MarketBeat

Dec 07, 2025
pulisher
Dec 04, 2025

Nkarta Inc (NKTX) Performance and Fundamentals Dashboard tells a completely different story - setenews.com

Dec 04, 2025
pulisher
Dec 04, 2025

We Think Nkarta (NASDAQ:NKTX) Needs To Drive Business Growth Carefully - Yahoo Finance

Dec 04, 2025
pulisher
Dec 04, 2025

Why Nkarta Inc. stock remains undervaluedBond Market & Weekly Return Optimization Alerts - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

Nkarta to Participate in Evercore Healthcare Conference - The Manila Times

Dec 02, 2025
pulisher
Dec 02, 2025

Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Dec 02, 2025
pulisher
Dec 02, 2025

Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 02, 2025
pulisher
Nov 30, 2025

Nkarta (NASDAQ:NKTX) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Nov 30, 2025
pulisher
Nov 28, 2025

It is Poised to be a Bull Market for Nkarta Inc (NKTX) - setenews.com

Nov 28, 2025
pulisher
Nov 22, 2025

Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha

Nov 22, 2025
pulisher
Nov 21, 2025

How interest rate cuts could boost Nkarta Inc. stockMarket Activity Report & Low Risk Growth Stock Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Nkarta Inc. stock appeals to dividend seekers2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Using Python tools to backtest Nkarta Inc. strategiesWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Nkarta Inc. stock split again soonJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Nkarta Inc. stock benefits from strong dollarOil Prices & Reliable Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

A better buy-in window may exist right now for Nkarta Inc (NKTX) - setenews.com

Nov 19, 2025
pulisher
Nov 19, 2025

What momentum indicators show for Nkarta Inc. stockTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is it time to cut losses on Nkarta Inc.Product Launch & Comprehensive Market Scan Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will Nkarta Inc. stock deliver strong dividend growthSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Nkarta, Inc.Common Stock (NQ: NKTX - Markets Financial Content

Nov 18, 2025
pulisher
Nov 16, 2025

Will Nkarta Inc. stock sustain high P E ratiosJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Nkarta reports Q3 EPS (29c), consensus (30c) - MSN

Nov 16, 2025

Finanzdaten der Nkarta Inc-Aktie (NKTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Nkarta Inc-Aktie (NKTX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Shook David
See Remarks
Jan 15 '25
Sale
2.20
8,638
19,004
190,955
Levin Alyssa
See Remarks
Jan 15 '25
Sale
2.20
5,838
12,844
102,662
Brandenberger Ralph
Chief Technical Officer
Jan 15 '25
Sale
2.20
7,447
16,383
124,796
HASTINGS PAUL J
Chief Executive Officer
Jan 15 '25
Sale
2.20
17,378
38,232
319,859
Hager Alicia J.
Chief Legal Officer
Jan 15 '25
Sale
2.20
9,584
21,085
146,735
$106.77
price up icon 0.59%
$34.16
price up icon 1.34%
$116.62
price up icon 8.60%
$99.59
price up icon 0.55%
biotechnology ONC
$336.57
price up icon 5.23%
$177.98
price up icon 3.78%
Kapitalisierung:     |  Volumen (24h):